FindTrial
Sign In

Retrospective Comparison of Robotic- and Video-assisted Thoracic Surgery after Neoadjuvant Therapy in Non-small Cell Lung Cancer

Safety and Efficacy of Rabotic-assisted Thoracic Surgery in Non-Small Cell Lung Cancer after Neoadjuvant Therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074661
Enrollment
Unknown
Registered
2023-08-11
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Grouping based on whether patients have undergone robotic-assisted thoracoscopic surgery:N/A

Sponsors

Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) 18-80 years old. 2) Pathological diagnosis of NSCLC, pathological staging of IB-IIIB(N2) (8th TNM Stage system). 3) Receiving neoadjuvant therapy 4) Receiving surgery after neoadjuvant therapy

Exclusion criteria

Exclusion criteria: 1) Without available clinical information. 2) Receiving wedge resection or segmentectomy.

Design outcomes

Primary

MeasureTime frame
R0 resection rate;Operation time ;Estimated blood loss;—

Secondary

MeasureTime frame
The rate of conversion to thoracotomy;—

Countries

China

Contacts

Public ContactWen-Zhao Zhong

Guangdong Lung Cancer Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China

syzhongwenzhao@mail.scut.edu.cn+86 136 0977 7314

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026